β¨ Medicinal Product Notices
23 OCTOBER 2008 NEW ZEALAND GAZETTE, No. 162 4249
Product: Pentasa
Active Ingredient: Mesalazine 1g
Dosage Form: Modified release granules
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Ferring A/S (Denmark), Vanlose, Denmark
Ferring International Centre SA, Chemin de la Vergognausaz, Switzerland
Product: Pentasa
Active Ingredient: Mesalazine 2g
Dosage Form: Modified release granules
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Ferring A/S (Denmark), Vanlose, Denmark
Ferring International Centre SA, Chemin de la Vergognausaz, Switzerland
QPharma AB, Malmo, Sweden
Inpac AB, Aldermansgatan, Lund, Sweden
Product: Pentasa
Active Ingredient: Mesalazine 250mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Ferring A/S (Denmark), Vanlose, Denmark
Pharbil Pharma GmbH Limited, Bielefeld, Germany
Product: Pentasa
Active Ingredient: Mesalazine 500mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturers: Ferring A/S (Denmark), Vanlose, Denmark
Ferring International Centre SA, Chemin de la Vergognausaz, Switzerland
Pharbil Pharma GmbH Limited, Bielefeld, Germany
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 10mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 20mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 40mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Product: Vytorin
Active Ingredients: Ezetimibe 10mg
Simvastatin 80mg
Dosage Form: Tablet
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturers: Merck Sharp & Dohme (Singapore) Limited, Singapore, Singapore
Merck Sharp & Dohme SpA, Pavia, Italy
Dated this 16th day of October 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7841
Next Page →
β¨ LLM interpretation of page content
π₯ Approval of Pentasa and Vytorin Products
π₯ Health & Social Welfare16 October 2008
Medicines, Approval, Pentasa, Vytorin, Mesalazine, Ezetimibe, Simvastatin
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
NZ Gazette 2008, No 162